Women’s Health Division Receives 2022 Award from Hologic Asia–Pacific

Posted at 09 Nov 2022

The Women’s Health Division received two major awards from Hologic Asia–Pacific (the Growth Champion vs Plan and the All Star Award)

The Women’s Health Division, with the ThinPrep Pap Test and Aptima HPV cervical cancer screening solutions from Hologic (USA), has played a key role in strengthening Golden Gate JSC’s reputation and position in the medical device market.
Present in Vietnam since 2009, these products are now widely trusted and used in over 40 hospitals and more than 650 obstetrics and gynecology clinics nationwide, contributing to the improvement of healthcare service quality for millions of Vietnamese women

The Women’s Health Division participated in Hologic’s Partner Kick-Off Meeting held in Penang, Malaysia

Thanks to the superiority of the products and the focus on training and technology transfer to hospitals and doctors nationwide, more than 3 million Vietnamese women have gained access to the world’s leading dual screening tests, and tens of thousands of women have been diagnosed early with cervical cancer, avoiding the risk of death and unnecessary medical interventions.

  • Trusted and used in over 40 hospitals and more than 650 obstetrics and gynecology clinics
  • Over 3 million women have undergone the ThinPrep Pap Test in the past 11 years
  • FDA-approved in the U.S. for all four test indications: ThinPrep Pap Test, Aptima HPV, Chlamydia, and Gonorrhea — in a single vial
  • An average of 55 abnormal results (ASCUS or higher) are detected per day

The Women’s Health Division has achieved significant milestones, including winning two awards in 2022 from Hologic Asia–Pacific (Growth Champion vs Plan and All Star Award).

Latest News